Woven EndoBridge装置多模式使用的临床与影像学结局:一项大型多中心研究
这项回顾性多中心研究纳入澳大利亚三家神经血管中心2017年5月至2023年9月使用WEB装置治疗的161例患者共169个动脉瘤,评估其安全性和有效性。结果显示满意闭塞率85.6%,末次随访86.7%患者维持良好功能状态,死亡率0.6%,血栓栓塞并发症率7.1%(n=12/161),术后无再破裂,手术相关出血率1.2%(n=2/169)。作者认为WEB是颅内动脉瘤安全有效的治疗方式,支持其扩大应用于宽颈分叉部动脉瘤之外。
要点
- 169个动脉瘤满意闭塞率85.6%,86.7%患者末次随访维持良好功能状态。
- 死亡率0.6%,血栓栓塞并发症率7.1%(n=12/161),手术相关出血率1.2%(n=2/169),无术后再破裂。
- 作者认为WEB安全有效,支持扩大应用于宽颈分叉部动脉瘤之外,但需进一步前瞻性研究。
核心结论
- 作者认为这项多中心研究强化了WEB装置作为颅内动脉瘤有效且安全治疗方式的地位,支持其扩大应用于宽颈分叉部动脉瘤之外。
- 作者指出需要进一步前瞻性研究来全面阐明其不断演变的作用。
研究设计与样本
- 回顾性分析,汇总澳大利亚三家大型神经血管中心2017年5月至2023年9月使用WEB装置治疗的患者数据。
- 病例系列涵盖宽颈分叉部、侧壁及不规则形状动脉瘤,以及既往接受过其他治疗策略的病例。
- 研究还包括WEB装置联合辅助血管内装置治疗动脉瘤的病例。
- 共纳入161例患者的169个动脉瘤。
主要发现
- 满意动脉瘤闭塞率为85.6%。
- 末次随访时86.7%的患者维持良好功能状态。
- 死亡率为0.6%。
- 血栓栓塞并发症率为7.1%(n=12/161)。
- 术后无再破裂病例,手术相关出血率低(1.2%,n=2/169)。
关键数值与推荐
- 满意动脉瘤闭塞率为85.6%。
- 末次随访良好功能状态率为86.7%。
- 死亡率为0.6%。
- 血栓栓塞并发症率为7.1%(n=12/161)。
- 手术相关出血率为1.2%(n=2/169)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Woven EndoBridge (WEB) is a device used for intrasaccular flow diversion, designed for the elimination of wide-necked bifurcation aneurysms from the circulation. In this study, we aim to assess the safety and efficacy of the WEB and its uses in treating aneurysms of different morphologies and locations. METHODS: In a retrospective analysis, we compiled a comprehensive dataset from patients treated with the WEB device across three major Australian neurovascular centers from May 2017 to September 2023. The case series encompassed a spectrum of aneurysm types, including wide-necked bifurcation, sidewall, and irregularly shaped aneurysms, as well as cases previously managed with alternative therapeutic strategies. This study additionally encompasses cases where aneurysms were managed using the WEB device in combination with supplementary endovascular devices. RESULTS: The study included 169 aneurysms in 161 patients. The rate of satisfactory aneurysm occlusion was 85.6%, with 86.7% of patients maintaining good functional status at their most recent follow-up. The procedure exhibited a low mortality rate of 0.6% and a thromboembolic complication rate of 7.1% (n = 12/161). There were no instances of postoperative re-rupture and the procedure-related hemorrhage rate was low (1.2%, n = 2/169), aligning with the literature regarding the safety and efficacy of the WEB device. CONCLUSIONS: Our multicenter trial reinforces the WEB device's role as an effective and safe modality for intracranial aneurysm management, supporting its expanded application beyond wide-necked bifurcation aneurysms. Further prospective studies are required to delineate its evolving role fully.
引用
- Nasra M, Pavlin-Premrl D, Protto S, et al. The Clinical and Radiological Outcomes of the Multimodal Use of the Woven EndoBridge Device: A Large Multicenter Study. World Neurosurg. 2024. PMID: 38763461. doi:10.1016/j.wneu.2024.05.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。